Related Experiment Video
Updated: Jul 20, 2026

Biomimetic Materials to Characterize Bacteria-host Interactions
Published on: November 16, 2015
Antimicrobial peptide GL13K immobilized onto SLA-treated titanium by silanization: antibacterial effect against
Yusang Li1, Ruiying Chen2, Fushi Wang1,3
1The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei-MOST) and Key Laboratory of Oral Biomedicine Ministry of Education, School and Hospital of Stomatology, Wuhan University Wuhan China xinjie.cai@whu.edu.cn wang.yn@whu.edu.cn.
Abstract:
Infection is the main reason for implant failure, and the incidence of drug-resistant bacterial infection has increased in recent years. Further, methicillin-resistant Staphylococcus aureus (MRSA)-related implant infection has become a serious worldwide threat. New strategies, other than antibiotics, to tackle drug-resistance, are of high clinical significance. Antimicrobial peptides show clear superiority over conventional antibiotics in inhibiting drug-resistant bacteria. In the present study, we combined the antimicrobial peptide, GL13K, with sandblasting and acid-etching (SLA)-treated titanium using a silane coupling agent. Field emission scanning electron microscopy images showed the morphology of the coating. Attenuated total reflectance Fourier transform infrared spectroscopy and X-ray photoelectron spectroscopy results confirmed loading of GL13K, and the hydrophilicity of the SLA-GL13K coating was evaluated by water contact angle analysis. The releasing study of samples showed that the coating has a sustained releasing profile. SLA-GL13K coating exhibited strong contact- and release-killing abilities against MRSA, E. coli, and S. aureus. Meanwhile, Cell Counting Kit 8 analysis and examination of cell morphology demonstrated that the SLA-GL13K coating had good cytocompatibility at antibacterial concentrations. Overall, all these results suggest that SLA-GL13K coating can be successfully fabricated using silanization, and is a promising candidate for controlling MRSA-induced implant-related infection.
Insights
A novel antimicrobial peptide coating, GL13K, on titanium implants effectively combats drug-resistant bacteria like MRSA. This coating shows strong antibacterial activity and good biocompatibility, offering a promising alternative to antibiotics for preventing implant infections.
Area of Science:
- Biomaterials Science
- Infectious Diseases
- Nanotechnology
Background:
- Implant failure due to bacterial infection, particularly from antibiotic-resistant strains like methicillin-resistant Staphylococcus aureus (MRSA), is a significant clinical challenge.
- Conventional antibiotics are becoming less effective against resistant bacteria, necessitating the development of alternative strategies.
Purpose of the Study:
- To develop and evaluate a novel antimicrobial peptide coating (GL13K) on sandblasted and acid-etched (SLA) titanium implants for combating drug-resistant bacterial infections.
- To assess the antibacterial efficacy, release profile, and cytocompatibility of the SLA-GL13K coating.
Main Methods:
- Fabrication of GL13K coating on SLA-treated titanium using a silane coupling agent.
- Characterization of the coating's morphology, chemical composition, and hydrophilicity using field emission scanning electron microscopy, attenuated total reflectance Fourier transform infrared spectroscopy, X-ray photoelectron spectroscopy, and water contact angle analysis.
- Evaluation of GL13K release profile, antibacterial activity against MRSA, E. coli, and S. aureus, and cytocompatibility using Cell Counting Kit 8 assays.
Main Results:
- The SLA-GL13K coating was successfully fabricated and characterized, confirming GL13K loading and altered surface properties.
- The coating demonstrated a sustained release of GL13K.
- SLA-GL13K coating exhibited potent contact- and release-killing effects against MRSA, E. coli, and S. aureus.
- The coating showed good cytocompatibility at effective antibacterial concentrations.
Conclusions:
- Silanization is an effective method for fabricating GL13K coatings on SLA-treated titanium implants.
- The SLA-GL13K coating presents a promising strategy for preventing and treating implant-related infections, particularly those caused by MRSA.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance

